[Idiopathic thrombocytopenic purpura: therapeutic aspects in the adult].
Canevari
A
A
Divisione di Ematologia, Policlinico San Matteo IRCCS, Pavia.
Pagnucco
G
G
Castelli
G
G
Livraghi
A
A
Santagostino
A
A
Bernasconi
C
C
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001327:Autoimmune Diseases / Q000628:therapy*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use; D004630:Emergencies; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017713:Platelet Transfusion; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology / Q000628:therapy*; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D014748:Vinca Alkaloids; D003520:Cyclophosphamide; D003613:Danazol
Porpora trombocitopenica idiopatica: aspetti terapeutici nell'adulto.